Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
05/18/2012 | WO2012006542A3 Method of detecting single nucleotide polymorphisms |
05/18/2012 | WO2012006447A3 Gene signatures for cancer prognosis |
05/18/2012 | WO2011163323A9 Modified carbonic anhydrase enzymes and their use in carbon dioxide sequestration and elimination |
05/18/2012 | WO2011161413A3 Method and device |
05/18/2012 | WO2011153121A3 A soluble and stable human 5-lipoxygenase |
05/18/2012 | WO2011149305A3 Method for detecting mycobacterium tuberculosis and nontuberculous mycobacteria by using dual real-time polymerase chain reaction |
05/18/2012 | WO2011149279A3 Method for detecting mycobacterium tuberculosis and nontuberculous mycobacteria using duplex polymerase chain reaction |
05/18/2012 | WO2011149255A3 Modified rnase h and detection of nucleic acid amplification |
05/18/2012 | WO2011148269A3 Differentiation of species within the mycobacterium tuberculosis complex |
05/18/2012 | WO2011122859A3 Composition for predicting chance of brain tumor recurrence and survival prognosis, and kit containing same |
05/18/2012 | WO2011119986A3 Methods for culturing and analyzing cells |
05/18/2012 | WO2011060552A9 Variegation in plants |
05/18/2012 | CA2817712A1 Immortalization of epithelial cells and methods of use |
05/18/2012 | CA2817587A1 Classification of nucleic acid templates |
05/18/2012 | CA2817390A1 Enrichment and identification of fetal cells in maternal blood and ligands for such use |
05/18/2012 | CA2817218A1 Nuclions and ribocapsids |
05/18/2012 | CA2817111A1 Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom |
05/18/2012 | CA2816603A1 Materials and methods related to microrna-21, mismatch repair, and colorectal cancer |
05/18/2012 | CA2816334A1 Recombinant p4 bacteriophage and methods for their use |
05/18/2012 | CA2811113A1 Skin permeating and cell entering (space) peptides and methods of use thereof |
05/18/2012 | CA2770841A1 High yielding soybean variety xb19d12 |
05/18/2012 | CA2770840A1 High yielding soybean variety xb25g12 |
05/18/2012 | CA2770839A1 High yielding soybean variety xb25e12 |
05/18/2012 | CA2770835A1 High yielding soybean variety xb22k12 |
05/18/2012 | CA2770830A1 High yielding soybean variety xb00n12 |
05/18/2012 | CA2770826A1 High yielding soybean variety xb25f12 |
05/17/2012 | US20120124685 Compositions and methods for gene expression and chromatin profiling of individual cell types within a tissue |
05/17/2012 | US20120124681 Dna fragment and pharmaceutical composition |
05/17/2012 | US20120124376 Information Processing System Using Nucleotide Sequence-Related Information |
05/17/2012 | US20120123695 Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies |
05/17/2012 | US20120123687 Analysis of dna samples |
05/17/2012 | US20120123685 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby |
05/17/2012 | US20120123093 Novel surface antigen |
05/17/2012 | US20120122991 Method for treating cancer by increasing amp-activated kinase activity |
05/17/2012 | US20120122981 Biomarkers Related to Insulin Resistance and Methods using the Same |
05/17/2012 | US20120122968 Use of dynamin ring stabilizers |
05/17/2012 | US20120122959 Targeting MicroRNAs for Metabolic Disorders |
05/17/2012 | US20120122958 Transcriptional repression leading to parkinson's disease |
05/17/2012 | US20120122954 Antisense Oligomers Targeting PCSK9 |
05/17/2012 | US20120122946 Polymorphisms for predicting disease and treatment outcome |
05/17/2012 | US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator |
05/17/2012 | US20120122916 Screening molecules with anti-prion activity: kits, methods and screened molecules |
05/17/2012 | US20120122831 Method and device for rapid detection of bacterial antibiotic resistance/susceptibility |
05/17/2012 | US20120122819 Guanine riboswitch binding compounds and their use as antibiotics |
05/17/2012 | US20120122801 Mannose-6-phosphate receptor mediated gene transfer into muscle cells |
05/17/2012 | US20120122795 Accelerated extension of axons |
05/17/2012 | US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death |
05/17/2012 | US20120122762 186 Human Secreted Proteins |
05/17/2012 | US20120122761 Methods for detecting a polymorphism in the nfkb1 gene promoter |
05/17/2012 | US20120122736 Sensors incorporating antibodies and methods of making and using the same |
05/17/2012 | US20120122732 Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules |
05/17/2012 | US20120122728 Method Of Screening Drugs For Reversal Of Amyloid Beta Neurotoxicity |
05/17/2012 | US20120122727 In vitro method for predicting whether a compound is genotoxic in vivo |
05/17/2012 | US20120122726 Markers for endometrial cancer |
05/17/2012 | US20120122725 Method of determining risk of a neuropsychiatric disorder |
05/17/2012 | US20120122719 Methods for PCR and HLA typing using unpurified samples |
05/17/2012 | US20120122718 BRM Expression and Related Diagnostics |
05/17/2012 | US20120122716 Cell line derived from the epithelial lining of the human endolymphatic sac in the inner ear |
05/17/2012 | US20120122705 Flow-through high hydrostatic pressure microfluidic sample preparation device and related methods therefor |
05/17/2012 | US20120122701 Methods for Non-Invasive Prenatal Paternity Testing |
05/17/2012 | US20120122700 Materials and methods for determining subtelomere dna sequence |
05/17/2012 | US20120122238 VMP-Like Sequences of Pathogenic Borrelia |
05/17/2012 | US20120122217 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
05/17/2012 | US20120122149 Absorbent bead concentration method that eliminates the need for centrifugation |
05/17/2012 | US20120122148 Media For The Specific Detection Of Gram-Negative Bacteria Resistant To Beta-Lactam Antibiotics |
05/17/2012 | US20120122147 Real-time method for the detection of viable micro-organisms |
05/17/2012 | US20120122146 Nanoparticle screening methods employing insects with blood brain barrier |
05/17/2012 | US20120122145 Insect-based ex vivo model for testing blood-brain barrier penetration and method for exposing insect brain to chemical compounds |
05/17/2012 | US20120122144 Methods employing insect models for determining intestinal absorption of chemical compounds |
05/17/2012 | US20120122143 Technique for determining maturity of a cell aggregation, image processing program and image processing device using the technique, and method for producing a cell aggregation |
05/17/2012 | US20120122142 Cell deposition system |
05/17/2012 | US20120122141 Point Source Diffusion Cell Activity Assay Apparatus |
05/17/2012 | US20120122140 Ultrasonic method for monitoring cell cultures |
05/17/2012 | US20120122139 Microfluidic device and hemoglobin measurement method using the same |
05/17/2012 | US20120122138 Consumable component kit |
05/17/2012 | US20120122137 Novel Nitroreductase Enzymatic Substrates |
05/17/2012 | US20120122136 Self-immolative probes for enzyme activity detection |
05/17/2012 | US20120122135 Novel Peptidase Substrates |
05/17/2012 | US20120122134 Novel Peptidase Substrates |
05/17/2012 | US20120122133 Novel devices for the detection of the presence and/or activity of proteases in biological samples |
05/17/2012 | US20120122132 Protein Structural Biomarkers to Guide Targeted Chemotherapies |
05/17/2012 | US20120122131 Simultaneous detection of metabolic enzyme activity and metabolite levels |
05/17/2012 | US20120122130 Coenzyme-Linked Glucose Dehydrogenase and Polynucleotide Encoding the Same |
05/17/2012 | US20120122116 Use of lymphocytes to measure anthrax lethal toxin activity |
05/17/2012 | US20120122113 Signature Of Secreted Protein Isoforms Specific To Ovarian Cancer |
05/17/2012 | US20120122112 Antibodies as a cancer diagnostic |
05/17/2012 | US20120122111 Rna sequence-specific mediators of rna interference |
05/17/2012 | US20120122110 Method for isolating cells |
05/17/2012 | US20120122109 Neural progenitor cells derived from embryonic stem cells |
05/17/2012 | US20120122108 Microfluidic cartridge |
05/17/2012 | US20120122107 Homeostatic multidomain protein, and uses for it |
05/17/2012 | US20120122106 Mutation Detection Assay |
05/17/2012 | US20120122105 Real time cleavage assay |
05/17/2012 | US20120122104 Triple-Stranded Nucleobase Structures and Uses Thereof |
05/17/2012 | US20120122103 Compositions for use in identification of bacteria |
05/17/2012 | US20120122102 Compositions for use in identification of bacteria |
05/17/2012 | US20120122101 Compositions for use in identification of bacteria |
05/17/2012 | US20120122100 Compositions for use in identification of bacteria |
05/17/2012 | US20120122099 Compositions for use in identification of bacteria |
05/17/2012 | US20120122098 Compositions for use in identification of bacteria |